Age, Homocysteine, and oxidative stress: Relation to hypertension and type 2 diabetes mellitus

Journal of the American College of Nutrition

Volumn 29, Issue 1, 2010, Pages 1-6

  Dominguez, Ligia J ^a   Galioto, Antonio ^a   Pineo, Antonella ^a   Ferlisi, Anna ^a   Ciaccio, Marcello ^b   Putignano, Ernesto ^a   Belvedere, Mario ^a   Costanza, Giuseppe ^a   Barbagallo, Mario ^a  

^a UNIVERSITY OF PALERMO   (Italy)

^b UNIVERSITY OF PALERMO   (Italy)

Author keywords

Cardiovascular risk; Diabetes mellitus; Homocysteine; Hypertension; Oxidative stress

Indexed keywords

CREATININE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HOMOCYSTEINE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALONALDEHYDE; REACTIVE OXYGEN METABOLITE; TRIACYLGLYCEROL;

ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRIC PARAMETERS; ARTICLE; BLOOD PRESSURE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; COMORBIDITY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC HYPERTENSION; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; SEX RATIO; SYSTOLIC BLOOD PRESSURE;

ADULT; AGE FACTORS; AGED; AGING; DIABETES MELLITUS, TYPE 2; FEMALE; HOMOCYSTEINE; HUMANS; HYPERTENSION; MALE; MALONDIALDEHYDE; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES;

EID: 77956489908     PISSN: 07315724     EISSN: 15411087     Source Type: Journal    
DOI: 10.1080/07315724.2010.10719810     Document Type: Article

References (32)

1. Welch GN, Loscalzo J: Homocysteine and atherothnombosis. N Engl J Med 338:1042-1050, 1998.
2. Wald DS, Law M, Morris JK: Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. B Med J 325:1202-1206, 2002.
3. Homocysteine Studies Collaboration: Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 288:2015-2022, 2002.
4. Ridker PM, Brown NJ, Vaughan DE, Harrison DG, Mehta JL: Established and emerging plasma biomarkers in the prediction of first atherothrombotic events. Circulation 109:IV6-19, 2004.
5. Ames BN, Shigenaga MK, Hagen TM: Oxidants, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sei U S A 90:7915-7922, 1993.
6. Touyz RM: Reactive oxygen species, vascular oxidative stress, and redox signaling in hypertension: what is the clinical significance? Hypertension 44:248-252, 2004.
7. Brownlee M: The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625, 2005.
8. Selhub J, Jacques PF, Wilson PW, Rush D, Rosenberg IH: Vitamin status and intake as primary detenninants of homocysteinemia in an elderly population. JAMA 270:2693-2698, 1993.
9. Lippi G, Arosio E, Prior M, Guidi G: Biochemical risk factors for cardiovascular disease in an aged male population: emerging vascular pathogens. Angiology 52:681-687, 2001.
10. Hannan D: Aging: a theory based on free radical and radiation chemistry. J Gerontol 11:298-300, 1956.
11. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, Jones DW, Materson BJ, Oparil S, Wright JT, Roccella EJ: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560-2572, 2003.
12. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R: Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903-1913, 2002.
13. American Diabetes Association: Clinical practice recommendations 2005. Diabetes Care 28(suppl 1):S1-S79, 2005.
14. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972.
15. Toole JOF, Malinow MR, Chambless LE, Spence JD, Pettigrcw LC, Howard VJ, Sides EG, Wang CH, Stampfer M: Lowering homocysteine in patients with ischemic stroke to prevent recurrent stroke, myocardial infarction, and death: the Vitamin Intervention for Stroke Prevention (VISP) randomized controlled trial. JAMA 291:565-575, 2004.
16. Bonaa KH, Njolstad I, Ueland PM, Schirmer H, Tverdal A, Steigen T, Wang H, Nordrehaug JE, Arnesen E, Rasmussen K: Homocysteine lowering and cardiovascular events after acute myocardial infarction. N Engl J Med 354:1578-1588, 2006.
17. Lonn E, Yusuf S, Arnold MJ, Sheridan P, Pogue J, Micks M, McQueen MJ, Probstfield J, Fodor G, Held C, Genest J: Homocysteine lowering with folic acid and B vitamins in vascular disease. N Engl J Med 354:1567-1577, 2006.
18. Ebbing M, Bleie 0, Ueland PM, Nordrehaug JE, Nilsen DW, Vollset SE, Refsum H, Pederson EKR, Nygard O: Mortality and cardiovascular events in patients treated with homocysteine-lowering B vitamins after coronary angiography. JAMA 300:795-804, 2008.
19. Albert CM, Cook NR, Gaziano JM, Zaharris E, MacFayden J, Danielson E, Buring JE, Manson JE: Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease. JAMA 299:2027-2036, 2008.
20. Kris-Etherton PM, Lichteastein AH, Howard BV, Steinberg D, Witztum JL: Antioxidant vitamin supplements and cardiovascular disease. Circulation 110:637-641, 2004.
21. Lakatta EG: Central arterial aging and the epidemic of systolic hypertension and atherosclerosis. J Am Soc Hyperteas 1:302-340, 2007.
22. McCully KS: Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis. Am J Pathol 56:111-128, 1969.
23. Mangoni AA, Jackson SH: Homocysteine and cardiovascular disease: current evidence and future prospects. Am J Med 112:556-565, 2002.
24. Gori AM, Corsi AM, Fedi S, Gazzini A, Sofi F, Bartali B, Bandinelli S, Geasini GF, Abbate R, Ferrucci L: A proinflamma-tory state is associated with hyperhomocysteinemia in the elderly. Am J Clin Nutr 82:335-341, 2005.
25. Lim U, Cassano PA: Homocysteine and blood pressure in the Third National Health and Nutrition Examination Survey, 1988-1994. Am J Epidemiol 156:1105-1113, 2002.
26. Signorello MG, Viviani GL, Armani U, Cerone R, Minniti G, Piana A, Leoncini G: Homocysteine, reactive oxygen species and nitric oxide in type 2 diabetes mellitus. Thromb Res 120:607-613, 2006.
27. van Güldener C, Stehouwer CD: Diabetes mellitus and hyperhomocysteinemia. Semin Vase Med 2:87-95, 2002.
28. Vangelder E, Delecourt F, Cardozo MB, Dhondt JL, Forzy G: Hyperhomocysteinaemia and type 2 diabetes. Ann Biol Clin 64:485-489, 2006.
29. Sigurdardottir V, Fagerberg B, Hulthe J: Circulating oxidized low-density lipoprotein (LDL) is associated with risk factors of the metabolic syndrome and LDL size in clinically healthy 58-year-old men (AIR study). J Intern Med 252:440-447, 2002.
30. Furukawa S, Fujita T, Shimabukuro M, Iwaki M, Yamada Y, Nakajima Y, Nakayama O, Makishima M, Matsuda M, Shimo-mura I: Increased oxidative stress in obesity and its impact on metabolic syndrome. J Clin Invest 114:1752-1761, 2004.
31. Tribble DL: AHA Science Advisory. Antioxidant consumption and risk of coronary heart disease: emphasison vitamin C, vitamin E, and beta-carotene: a statement for healthcare professionals from the American Heart Association. Circulation 99:591-595, 1999.
32. Stern MP: Diabetes and cardiovascular disease. The “common soil” hypothesis. Diabetes 44:369-374, 1995.